The impact of state policy on the costs of HIV infection

Medical Care Research and Review

Volumn 58, Issue 1, 2001, Pages 31-53

  Goldman, Dana P ^a   Bhattacharya, Jayanta ^a   Leibowitz, Arleen A ^b   Joyce, Geoffrey F ^a   Shapiro, Martin F ^b   Bozzette, Samuel A ^c  

^a RAND   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; EMPLOYMENT; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HOSPITAL COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; MEDICAID; OUTCOMES RESEARCH;

ADULT; AGED; ANTI-HIV AGENTS; DRUG COSTS; DRUG THERAPY, COMBINATION; ELIGIBILITY DETERMINATION; FEMALE; HEALTH CARE COSTS; HEALTH POLICY; HIV INFECTIONS; HUMANS; MALE; MEDICAID; MEDICAL ASSISTANCE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); STATE HEALTH PLANS; UNITED STATES;

EID: 0035129492     PISSN: 10775587     EISSN: None     Source Type: Journal    
DOI: 10.1177/107755870105800102     Document Type: Article

References (39)

1. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV in the U.S.
2. Health interview responses compared to medical records
3. The care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study
4. Data frequency effect in the National Medical Care Expenditure Survey
5. Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy
6. HIV-1 protease inhibitors. A review for clinicians
7. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy
8. Smearing estimate: A nonparametric retransformation method
9. National probability samples in studies of low-prevalence diseases, part 2: Designing and implementing the HIV cost and services utilization study sample
10. The effects of benefit design and managed care on health care costs
11. AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy
12. Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients
13. Recall strategies and memory for health-care visits
14. Human immunodeficiency virus disease in the era of HAART: A reevaluation of the mucocutaneous manifestations
15. Variation in inpatient resource use in the treatment of HIV - Do the privately insured receive more care?
16. Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection
17. A cognitive approach to enhancing health survey reports of medical visits
18. Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy
19. Incentive effects of the U.S. welfare system: A review
20. Decreased medical expenditures for care of HIV-seropositive patients: The impact of highly active antiretroviral therapy at a US Veterans Affairs Medical Center
21. Combination antiretroviral therapy in HIV infection: An economic perspective
22. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres: Federation National des Centres de Lutte contre le SIDA
23. Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy
24. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV outpatient study investigators
25. Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients: Swiss HIV Cohort Study
26. Immune function and phenotype before and after highly active antiretroviral therapy
27. Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center
28. Effects of time and memory factors on response surveys
29. Impact of combination therapy for HIV infection on inpatient census